Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Avalon (Computer Aided Diagnosis)

Avalon (Computer Aided Diagnosis)
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
3 INVESTORS
Description

Developer of a diagnostic tool designed to detect brain degenerative diseases like Alzheimer. The company's diagnostic tool uses machine learning algorithms to analyse brain MRIs and detect patients with mild cognitive impairment that will progress to dementia within one year, enabling medical professionals and pharmaceutical companies to run clinical trials and enroll only the mild cognitive impairment patients.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Diagnostic Equipment
Primary Office
  • Vine Yard Studios 13 18
  • Shaftesbury Road
  • London E7 8PY
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Avalon (Computer Aided Diagnosis)’s full profile, request a free trial.

Avalon (Computer Aided Diagnosis) Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 13-Feb-2017 00000 Completed Startup
2. Accelerator/Incubator 20-Jun-2016 00000 00000 Completed Startup
1. Accelerator/Incubator 09-Mar-2016 $24.4K $24.4K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Avalon (Computer Aided Diagnosis) Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
TMC Innovation Accelerator/Incubator 000 0000 000000 0
Techstars Accelerator/Incubator Minority 000 0000 000000 0
Entrepreneur First Accelerator/Incubator Minority 000 0000 000000 0

Avalon (Computer Aided Diagnosis) Executive Team (2)

Name Title Board
Seat
Contact
Info
Olivier van den Biggelaar Ph.D Co-Founder & Chief Executive Officer
Alejandro Vicente Grabovetsky Ph.D Co-Founder & Chief Scientific Officer